Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Laurent Deville

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Cancer Chemotherapy and Pharmacology|February 11, 2022
Adaptive dosing of sunitinib in a metastatic renal cell carcinoma patient: when in silico modeling helps to go quicker to the pointFlorent Ferrer, Jonathan Chauvin, Jean-Laurent Deville, et al.
La Revue Du Praticien|December 5, 2018
Florence Duffaud, Marie Fichaux, Jean-Laurent Deville, et al.
Expert Opinion on Therapeutic Targets|September 18, 2010
Adrenomedullin as a therapeutic target in angiogenesisJean-Laurent Deville, Sébastien Salas, Dominique Figarella-Branger, et al.
Pharmaceuticals (Basel, Switzerland)|June 2, 2021
Clinical-Based vs. Model-Based Adaptive Dosing Strategy: Retrospective Comparison in Real-World mRCC Patients Treated with SunitinibFlorent Ferrer, Jonathan Chauvin, Bénédicte DeVictor, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 14, 2020
A simple and rapid liquid chromatography-mass spectrometry method to assay cabozantinib in plasma: Application to therapeutic drug monitoring in patients with renal cell carcinomaFlorent Ferrer, Caroline Solas, Madeline Giocanti, et al.
Oncology Letters|March 15, 2019
Rechallenge of carboplatin-gemcitabine based chemotherapy for rapidly progressing metastatic collecting duct carcinoma of the kidney leading to a delayed and durable complete response: A case reportDomitille Dano, Clémence Delteil, Romain Boissier, et al.
Anti-Cancer Drugs|March 22, 2018
Acute myositis: an unusual and severe side effect of docetaxel: a case report and literature reviewPhilippe Rochigneux, Nicolas Schleinitz, Mikael Ebbo, et al.
Anticancer Research|January 31, 2012
Complete pathological response after sequential therapy with sunitinib and radiotherapy for metastatic clear cell renal carcinomaGeoffroy Venton, Aurelie Ducournau, Emmanuel Gross, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|August 28, 2016
Computerized Provider Order Entry Using Two Prescription-Writing Software in OncologyAmaury Guédon, Angélique Rome, Jean-Laurent Deville, et al.
Clinical Genitourinary Cancer|December 25, 2024
A French Multicenter Real-Life Study on the Biological and Clinical Parameters Associated With Response to Immune Checkpoint Inhibitors (ICIs) in Second-Line Treatment of Advanced Urothelial Carcinoma: Impact of Antibiotics Administration at the Time of ICIs InitiationPierre Grassi, Werner Hilgers, Romain Boissier, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|February 11, 2022
Adaptive dosing of sunitinib in a metastatic renal cell carcinoma patient: when in silico modeling helps to go quicker to the pointFlorent Ferrer, Jonathan Chauvin, Jean-Laurent Deville, et al.
La Revue Du Praticien|December 5, 2018
Florence Duffaud, Marie Fichaux, Jean-Laurent Deville, et al.
Expert Opinion on Therapeutic Targets|September 18, 2010
Adrenomedullin as a therapeutic target in angiogenesisJean-Laurent Deville, Sébastien Salas, Dominique Figarella-Branger, et al.
Pharmaceuticals (Basel, Switzerland)|June 2, 2021
Clinical-Based vs. Model-Based Adaptive Dosing Strategy: Retrospective Comparison in Real-World mRCC Patients Treated with SunitinibFlorent Ferrer, Jonathan Chauvin, Bénédicte DeVictor, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 14, 2020
A simple and rapid liquid chromatography-mass spectrometry method to assay cabozantinib in plasma: Application to therapeutic drug monitoring in patients with renal cell carcinomaFlorent Ferrer, Caroline Solas, Madeline Giocanti, et al.
Oncology Letters|March 15, 2019
Rechallenge of carboplatin-gemcitabine based chemotherapy for rapidly progressing metastatic collecting duct carcinoma of the kidney leading to a delayed and durable complete response: A case reportDomitille Dano, Clémence Delteil, Romain Boissier, et al.
Anti-Cancer Drugs|March 22, 2018
Acute myositis: an unusual and severe side effect of docetaxel: a case report and literature reviewPhilippe Rochigneux, Nicolas Schleinitz, Mikael Ebbo, et al.
Anticancer Research|January 31, 2012
Complete pathological response after sequential therapy with sunitinib and radiotherapy for metastatic clear cell renal carcinomaGeoffroy Venton, Aurelie Ducournau, Emmanuel Gross, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|August 28, 2016
Computerized Provider Order Entry Using Two Prescription-Writing Software in OncologyAmaury Guédon, Angélique Rome, Jean-Laurent Deville, et al.
Clinical Genitourinary Cancer|December 25, 2024
A French Multicenter Real-Life Study on the Biological and Clinical Parameters Associated With Response to Immune Checkpoint Inhibitors (ICIs) in Second-Line Treatment of Advanced Urothelial Carcinoma: Impact of Antibiotics Administration at the Time of ICIs InitiationPierre Grassi, Werner Hilgers, Romain Boissier, et al.
Pageof 4